News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Diana Brixner

Articles by Diana Brixner

97 Treatment Discontinuation Among Patients With Stage IV HER2–Negative Breast Cancer

ByChia Jie Tan,Connor Willis,Trang Au,Matthew Schabath, PhD,Chenghui Li,Kristen Kelley,Xiaoqing Xu,Leah Park,Clara Lam,Sandhya Mehta,Jackie Kwong,Diana Brixner,David Stenehjem

April 17th 2025

Latest Updated Articles

Trending on CancerNetwork

Ziftomenib Plus 7+3 Yields High Response Rates in Newly Diagnosed AML

Arlo-Cel Produces Deep Responses in Pretreated R/R Multiple Myeloma

Pirtobrutinib Plus Venetoclax/Rituximab Improves PFS in Pretreated CLL

Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL

FDA Clears Alpha DaRT Trial to Complete Enrollment in Recurrent GBM